Legal Representation
Attorney
Richard A. Friedman
USPTO Deadlines
Next Deadline
178 days remaining
NOA E-Mailed - SOU Required
Due Date
June 18, 2026
Extension Available
Until December 18, 2026
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 25, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 24, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 24, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Nov 24, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 15, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 28, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 28, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 28, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 6, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 6, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 6, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 6, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 18, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 23, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 23, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 3, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 12, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 7, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 29, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 3, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
Classification
International Classes
005